The company behind Tylenol is firing back after Trump and Robert F. Kennedy Jr. claimed that acetaminophen use during pregnancy could be linked to autism.
Kenvue, the maker of Tylenol, released a strong statement saying the science is clear: acetaminophen does not cause autism. The company pointed out that decades of research and independent reviews support Tylenol as a safe option for pregnant women when taken as directed.
During a press conference, Trump and Kennedy suggested pregnant women avoid the medication altogether, warning of possible risks. The administration also announced plans to change drug labels, alert physicians, and launch a public health campaign.
Medical experts and professional groups quickly pushed back. Organizations like the American College of Obstetricians and Gynecologists stressed there is no proven link, warning that discouraging use could leave pregnant women without safe options to manage pain or fever.
Kenvue echoed those concerns, saying the administration’s claims could confuse families and lead to unnecessary fear.
International agencies are siding with Tylenol, too. The European Medicines Agency and the World Health Organization both reaffirmed that acetaminophen remains safe for use during pregnancy when recommended by doctors.
